Could a cough medicine combo ease OCD symptoms?

NCT ID NCT04899687

Recruiting now Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding dextromethorphan (a cough suppressant) to fluoxetine (an antidepressant) can safely reduce symptoms of obsessive-compulsive disorder (OCD) and related conditions like body dysmorphic disorder. About 60 adults in California will take the combination and be monitored for improvement using standard symptom scales. The goal is to see if this approach is tolerable and effective for symptom relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BODY DYSMORPHIC DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

body dysmorphic disorder hypochondriasis obsessive-compulsive disorder somatization disorder somatoform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BODY DYSMORPHIC DISORDERS ILLNESS ANXIETY DISORDER OBSESSIVE-COMPULSIVE DISORDER SOMATIC SYMPTOM DISORDER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Stanford University
RECRUITING

Stanford, California, 94304, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.